CATALYST PHARMACEU revenue breakdown overview

CATALYST PHARMACEU revenue for the last year amounted to 444.41 M CHF, the most of which — 446.59 M CHF — came from its highest performing source at the moment, Drug Products, the year earlier bringing 335.26 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought CATALYST PHARMACEU 446.59 M CHF, and the year before that — 335.26 M CHF.